Our Portfolio


Investment date
Named patient pharmaceutical supplier
Healthcare & Pharmaceuticals
Deal value
CBPE Capital LLP is not responsible for the content of external internet sites

In September 2005, CBPE backed the MBO of Idis, the market leading importer and supplier of unlicensed pharmaceuticals sourced from around the world. Its core activities are: (a) the sourcing and supply (with appropriate regulatory approval) of drugs which are currently unlicensed within a domestic territory from an overseas territory where they are licensed; and (b) the creation of access to drugs still in investigational phase to patients with clear unmet medical needs.

Idis is also the leading provider of global managed access solutions to pharmaceutical and biotech clients. In partnership with these clients, operating on a named-patient basis, Idis provides global services to hospital and retail based pharmacists acting at the request of the prescribing hospital physician.

Idis is based in the US and has its headquarters in the UK.

legal & privacy | use of cookies CBPE Capital LLP is authorised and regulated by the Financial Conduct Authority
CBPE Capital is committed to conform with the Walker guidelines
Copyright © 2014 CBPE Capital LLP. All rights reserved